Volume 8, Issue 11.
In this issue:
Inhaled antibiotics have become the foundation of treating chronic respiratory tract Pseudomonas infection in individuals with cystic fibrosis. But what happens when inhaled monotherapy doesn’t sufficiently manage the symptoms? Which patients are appropriate candidates for treatment with multiple inhaled agents? Which medications are appropriate for continuous alternating therapy (CAT)?
In this Issue, Dr. Elliott Dasenbrook from the Cleveland Clinic brings the evidence he analyzed in his recent eCysticFibrosis Review Newsletter issue (Vol 8; Issue 10) into the clinic to help guide clinical decision-making.
Take our post-test to claim CME credits.
To read a companion newsletter click here.
Podcast (ecystic): Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS